Anzeige
❌
Mehr »
Freitag, 17.04.2026 - Börsentäglich über 12.000 News
Deutliche Überlegenheit der Erzgehalte: Die Zahlen lügen nicht
Anzeige

Indizes
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Aktien
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Xetra-Orderbuch

Fonds
Kurs
%

Devisen
Kurs
%

Rohstoffe
Kurs
%

Themen
Kurs
%

Erweiterte Suche

WKN: A40NBL | ISIN: SE0022726139 | Ticker-Symbol: N/A
Frankfurt
04.03.26 | 08:21
0,001 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
nicht mehr börsennotiert
1-Jahres-Chart  (nicht börsennotiert)
CHORDATE MEDICAL HOLDING AB Chart 1 Jahr

Aktuelle News zur CHORDATE MEDICAL

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12.03.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 12.03.2026577Xetra NewsboardThe following instruments on Boerse Frankfurt do have their last trading day on 12.03.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 12.03.2026.ISIN NameCA53044R8839 LIB.DEF.HO....
► Artikel lesen
CHORDATE MEDICAL Aktie jetzt für 0€ handeln
05.03.XFRA K1Z0: AUSSETZUNG/SUSPENSION241Xetra NewsboardDAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCHORDATE MEDICAL...
► Artikel lesen
18.02.Chordate Medical Holding AB: Chordate Medical's application for delisting has been approved196GlobeNewswire (Europe)Chordate Medical Holding AB (publ) ("Chordate" or "the Company") application for delisting of the Company's ordinary shares with ISIN SE0022726139 and preference shares with ISIN SE0023848619 has now...
► Artikel lesen
18.02.Chordate Medical Holding AB: Chordate Medical applies for delisting512GlobeNewswire (Europe)Following the general meeting of Chordate Medical Holding AB (publ) ("Chordate" or "the Company") resolution to delist the Company's shares and to liquidate the Company, the liquidator has decided to...
► Artikel lesen
16.01.Chordate Medical Holding AB: Chordate Medical announces updated timetable for delisting198GlobeNewswire (Europe)The general meeting of Chordate Medical Holding AB (publ) ("Chordate" or "the Company") resolved at an extraordinary general meeting on 8 December 2025, among other things, to delist the Company's shares....
► Artikel lesen
16.12.25Chordate Medical Holding AB: Chordate Medical terminates the liquidity guarantee for the common share225GlobeNewswire (Europe)Chordate Medical hereby announces that the company has terminated the agreement with Lago Kapital regarding the assignment as liquidity provider for the common share CMH. The purpose of the liquidity...
► Artikel lesen
08.12.25Chordate Medical Holding AB: Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ)154GlobeNewswire (Europe)At the Extraordinary General Meeting of Chordate Medical Holding AB (publ), held on December 8, 2025, the following resolution was passed. All resolutions were adopted in accordance with the proposals...
► Artikel lesen
19.11.25Chordate Medical Holding AB (publ) receives observation status191GlobeNewswireYesterday, November 18, 2025, Chordate Medical Holding AB (publ) (the "Company") disclosed a notice convening an extraordinary general meeting of the Company's shareholders, with a proposal for voluntary...
► Artikel lesen
21.08.25Chordate Medical Holding AB: Chordate Medical Announces Cost Reduction and Focus on Company Sale225GlobeNewswire (Europe)Chordate Medical Holding AB (Publ.) (the "Company") has adopted a cost reduction program that includes focusing activities on the continued ambition to sell the Company. Together with the recently completed...
► Artikel lesen
19.08.25Chordate Medical Holding AB: Chordate Medical reports preliminary conclusions from long-term study on chronic migraine: PM010244GlobeNewswire (Europe)Since this Post Market Surveillance study is open-label (uncontrolled), it is possible - and the sponsor's responsibility - to actively monitor study data during the ongoing trial. It is both scientifically...
► Artikel lesen
17.07.25Chordate Medical Holding AB: Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ)322GlobeNewswire (Europe)At the Extraordinary General Meeting of Chordate Medical Holding AB (publ), held on 17 July 2025, the following resolution was passed. All resolutions were adopted in accordance with the proposals previously...
► Artikel lesen
23.05.25Chordate Medical Holding AB: Interim Report January-March 2025283GlobeNewswire (Europe)Summary of the period January-March 2025Net turnover was SEK 596,105 (257,677)Cash flow from operating activities was SEK -6,046,406 (-5,908,058)Profit/loss after financial items was SEK -5,756,609...
► Artikel lesen
12 Nachrichten in den letzten 12 Monaten